Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19
Abstract Background There is no proven antiviral or immunomodulatory therapy for coronavirus disease 2019 (COVID-19). The disease progression associated with the proinflammatory host response prompted us to examine the role of early corticosteroid therapy in patients with moderate to severe COVID-19...
Saved in:
Published in | Clinical infectious diseases Vol. 71; no. 16; pp. 2114 - 2120 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
19.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!